A programmatic approach to patient blood management – Reducing transfusions and improving patient outcomes

Open Anesthesiology Journal

Volumn 9, Issue , 2015, Pages 6-16

  Farmer, Shannon L ^a,b   Trentino, Kevin ^c   Hofmann, Axel ^a,b,d   Semmens, James B ^b   Mukhtar, S Aqif ^b   Prosser, Gareth ^a,e   Hamdorf, Jeffrey M ^a   Rao, Sudhakar ^f   Leahy, Michael F ^e,g  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b CURTIN UNIVERSITY   (Australia)

^c WA Department of Health   (Australia)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e FREMANTLE HOSPITAL   (Australia)

^f ROYAL PERTH HOSPITAL   (Australia)

^g UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Anemia; Blood conservation; Blood loss; Blood transfusion; Bloodless surgery; Patient blood management; Practice change

Indexed keywords

ARTICLE; BLEEDING; BLOOD CONSERVATION; BLOOD TRANSFUSION; ERYTHROCYTE TRANSFUSION; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; INFECTION; LENGTH OF STAY; OUTCOME ASSESSMENT; PATIENT BLOOD MANAGEMENT PROGRAM; PATIENT CARE; PATIENT SAFETY; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; SOCIOECONOMICS;

EID: 84977957657     PISSN: None     EISSN: 18743218     Source Type: Journal    
DOI: 10.2174/1874321801509010006     Document Type: Article

References (92)

1. Isbister JP. The three-pillar matrix of patient blood management - an overview. Best Pract Res Clin Anaesthesiol 2013; 27(1): 69-84.
2. Hofmann A, Farmer S, Shander A. Five drivers shifting the paradigm from product-focused transfusion practice to patient blood management. Oncologist 2011; 16 (Suppl 3): 3-11.
3. Hofmann A, Farmer S, Towler SC. Strategies to preempt and reduce the use of blood products: an Australian perspective. Curr Opin Anaesthesiol 2012; 25(1): 66-73.
4. Thomson A, Farmer S, Hofmann A, et al. Patient Blood Management - a new paradigm for transfusion medicine? ISBT Sci Ser 2009; 4: 423-35.
5. Waters JH, Ness PM. Patient blood management: a growing challenge and opportunity. Transfusion 2011; 51(5): 902-3.
6. Sixty-third World Health Assembly, Resolution WHA63.12, Availability, safety and quality of blood products 2010. Available from: http://apps.who.int/gb/ebwha/pdf_files/WHA63-REC1/WHA63_ REC1-en.pdf
7. Martyn V, Farmer SL, Wren MN, et al. The theory and practice of bloodless surgery. Transfus Apher Sci 2002; 27(1): 29-43.
8. Goodnough LT, Shander A. Blood management. Arch Pathol Lab Med 2007; 131(5): 695-701.
9. Ferraris VA, Ferraris SP, Saha SP, et al. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiolo-gists clinical practice guideline. Ann Thorac Surg 2007; 83(5 Suppl): S27-86.
10. NBA. Patient Blood Management Guidelines: Module 2 Perioperative. Canberra, Australia: National Blood Authority (NBA); 2012. Available from: http://www.blood.gov.au/pbmmodule- 2
11. LaPar DJ, Crosby IK, Ailawadi G, et al. Blood product conservation is associated with improved outcomes and reduced costs after cardiac surgery. J Thorac Cardiovasc Surg 2013; 145(3): 796-803.
12. Kotze A, Carter LA, Scally AJ. Effect of a patient blood management programme on preoperative anaemia, transfusion rate, and outcome after primary hip or knee arthroplasty: a quality improvement cycle. Br J Anaesth 2012; 108(6): 943-52.
13. Moskowitz DM, McCullough JN, Shander A, et al. The impact of blood conservation on outcomes in cardiac surgery: is it safe and effective? Ann Thorac Surg 2010; 90(2): 451-8.
14. Reddy SM, Talwar S, Velayoudam D, et al. Multi-modality blood conservation strategy in open-heart surgery: an audit. Interact Cardiovasc Thorac Surg 2009; 9(3): 480-2.
15. Brevig J, McDonald J, Zelinka ES, et al. Blood transfusion reduction in cardiac surgery: multidisciplinary approach at a community hospital. Ann Thorac Surg 2009; 87(2): 532-9.
16. Wong CJ, Vandervoort MK, Vandervoort SL, et al. A clusterrandomized controlled trial of a blood conservation algorithm in patients undergoing total hip joint arthroplasty. Transfusion 2007; 47(5): 832-41.
17. Ghiglione M. Blood management: a model of excellence. Clin Leadersh Manag Rev 2007; 21(2): E2.
18. Freedman J, Luke K, Escobar M, et al. Experience of a network of transfusion coordinators for blood conservation (Ontario Transfusion Coordinators [ONTraC]). Transfusion 2008; 48(2): 237-50.
19. Martinez V, Monsaingeon-Lion A, Cherif K, et al. Transfusion strategy for primary knee and hip arthroplasty: impact of an algorithm to lower transfusion rates and hospital costs. Br J Anaesth 2007; 99(6): 794-800.
20. DeAnda A Jr., Baker KM, Roseff SD, et al. Developing a blood conservation program in cardiac surgery. Am J Med Qual 2006; 21(4): 230-7.
21. Freedman J, Luke K, Monga N, et al. A provincial program of blood conservation: The Ontario Transfusion Coordinators (ONTraC). Transfus Apher Sci 2005; 33(3): 343-9.
22. Pierson JL, Hannon TJ, Earles DR. A blood-conservation algorithm to reduce blood transfusions after total hip and knee arthroplasty. J Bone Joint Surg Am 2004; 86-A(7): 1512-8.
23. Green JA. Blood conservation in cardiac surgery: the Virginia Commonwealth University (VCU) experience. J Cardiothorac Vasc Anesth 2004; 18(4 Suppl): 18S-23S.
24. Kourtzis N, Pafilas D, Kasimatis G. Blood saving protocol in elective total knee arthroplasty. Am J Surg 2004; 187(2): 261-7.
25. Morgan TO. Blood conservation: the CEO perspective. J Cardiothorac Vasc Anesth 2004; 18(4 Suppl): 15S-7S.
26. Slappendel R, Dirksen R, Weber EW, van der Schaaf DB. An algorithm to reduce allogenic red blood cell transfusions for major orthopedic surgery. Acta Orthop Scand 2003; 74(5): 569-75.
27. Van der Linden P, De Hert S, Daper A, et al. A standardized multidisciplinary approach reduces the use of allogeneic blood products in patients undergoing cardiac surgery. Can J Anaesth 2001; 48(9): 894-901.
28. Helm RE, Rosengart TK, Gomez M, et al. Comprehensive multimodality blood conservation: 100 consecutive CABG operations without transfusion. Ann Thorac Surg 1998; 65(1): 125-36.
29. Frank SM, Wick EC, Dezern AE, et al. Risk-adjusted clinical outcomes in patients enrolled in a bloodless program. Transfusion 2014; 54(10 pt 2): 2668-17.
30. Pattakos G, Koch CG, Brizzio ME, et al. Outcome of patients who refuse transfusion after cardiac surgery: a natural experiment with severe blood conservation. Arch Int Med 2012; 172(15): 1154-60.
31. Farmer SL, Towler SC, Leahy MF, Hofmann A. Drivers for change: Western Australia Patient Blood Management Program (WA PBMP), World Health Assembly (WHA) and Advisory Committee on Blood Safety and Availability (ACBSA). Best Pract Res Clin Anaesthesiol 2013; 27(1): 43-58.
32. Isbister JP. The paradigm shift in blood transfusion. Med J Aust 1988; 148(6): 306-8.
33. Mortimer PP. Making blood safer. BMJ 2002; 325(7361): 400-1.
34. Farmer SL, Isbister JP, Leahy MF. History of transfusion and patient blood management. In: Jabbour N, ed. Transfusion free medicine and surgery. 2nd ed. Malden, Mass: Wiley-Blackwell 2014.
35. Boucher BA, Hannon TJ. Blood management: a primer for clinicians. Pharmacotherapy 2007; 27(10): 1394-411.
36. Dzik WH. Emily Cooley Lecture 2002: transfusion safety in the hospital. Transfusion 2003; 43(9): 1190-9.
37. Hofmann A, Farmer S, Shander A. Cost-effectiveness in haemotherapies and transfusion medicine. ISBT Sci Ser 2009; 4: 423-35.
38. The cost of blood: multidisciplinary consensus conference for a standard methodology. Transfus Med Rev 2005; 19(1): 66-78.
39. Shander A, Hofmann A, Gombotz H, et al. Estimating the cost of blood: past, present, and future directions. Best Pract Res Clin Anaesthesiol 2007; 21(2): 271-89.
40. Shander A, Hofmann A, Ozawa S, et al. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010; 50: 753-65.
41. Trentino KM, Farmer SL, Swain SG, et al. Increased hospital costs associated with red blood cell transfusion. Transfusion 2015; 55(5):1082-9.
42. EUPHIX European Union Public Health Information System. Available at: http://preview.euphix.org/object_class/euph_population by gender age.html [Access May 2015].
43. Cobain TJ, Vamvakas EC, Wells A, Titlestad K. A survey of the demographics of blood use. Transfus Med 2007; 17(1): 1-15.
44. Ali A, Auvinen MK, Rautonen J. The aging population poses a global challenge for blood services. Transfusion 2010; 50(3): 584-8.
45. Alter HJ, Stramer SL, Dodd RY. Emerging infectious diseases that threaten the blood supply. Semin Hematol 2007; 44(1): 32-41.
46. Blajchman MA, Vamvakas EC. The continuing risk of transfusiontransmitted infections. N Engl J Med 2006; 355(13): 1303-5.
47. Gallagher LM, Ganz PR, Yang H, et al. Advancing risk assessment for emerging infectious diseases for blood and blood products: proceedings of a public workshop. Transfusion 2013; 53(2): 455-63.
48. Vamvakas EC, Blajchman MA. Blood still kills: six strategies to further reduce allogeneic blood transfusion-related mortality. Transfus Med Rev 2010; 24(2): 77-124.
49. Farmer S, Isbister J, Hofmann A. Transfusion and outcomes. In: Gombotz H, Zacharowski K, Spahn D, eds. Patient Blood Management. 2nd ed. Rudigerstr, Stuttgart: Georg Thieme Verlag KG 2014 (in press).
50. Curry N, Stanworth S, Hopewell S, et al. Trauma-induced coagulopathy--a review of the systematic reviews: is there sufficient evidence to guide clinical transfusion practice? Transfus Med Rev 2011; 25(3): 217-31 e2.
51. Napolitano LM, Kurek S, Luchette FA, et al. Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. J Trauma 2009; 67(6): 1439-42.
52. Carson JL, Carless PA, Hebert PC. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2012; 4: CD002042.
53. Salpeter SR, Buckley JS, Chatterjee S. Impact of more restrictive blood transfusion strategies on clinical outcomes: a meta-analysis and systematic review. Am J Med 2014; 127(2): 124-31 e3.
54. Shander A, Fink A, Javidroozi M, et al. Appropriateness of allogeneic red blood cell transfusion: the international consensus conference on transfusion outcomes. Transfus Med Rev 2011; 25(3): 232-46 e53.
55. Vlahakes GJ. The value of phase 4 clinical testing. N Engl J Med 2006; 354(4): 413-5.
56. Isbister JP, Shander A, Spahn DR, et al. Adverse blood transfusion outcomes: establishing causation. Transfus Med Rev 2011; 25(2): 89-101.
57. Bernard AC, Davenport DL, Chang PK, et al. Intraoperative transfusion of 1 U to 2 U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients. J Am Coll Surg 2009; 208(5): 931-7, 7 e1-2.
58. Ferraris VA, Davenport DL, Saha SP, et al. Intraoperative transfusion of small amounts of blood heralds worse postoperative outcome in patients having noncardiac thoracic operations. Ann Thorac Surg 2011; 91(6): 1674-80.
59. Ferraris VA, Davenport DL, Saha SP, et al. Surgical outcomes and transfusion of minimal amounts of blood in the operating room. Arch Surg 2012; 147(1): 49-55.
60. Paone G, Likosky DS, Brewer R, et al. Transfusion of 1 and 2 units of red blood cells is associated with increased morbidity and mortality. Ann Thorac Surg 2014; 97(1): 87-93.
61. Tinmouth A, Chin-Yee I. The clinical consequences of the red cell storage lesion. Transfus Med Rev 2001; 15(2): 91-107.
62. Gladwin MT, Kanias T, Kim-Shapiro DB. Hemolysis and cell-free hemoglobin drive an intrinsic mechanism for human disease. J Clin Invest 2012; 122(4): 1205-8.
63. Tsai AG, Hofmann A, Cabrales P, Intaglietta M. Perfusion vs. oxygen delivery in transfusion with "fresh" and "old" red blood cells: the experimental evidence. Transfus Apher Sci 2010; 43(1): 69-78.
64. Donadee C, Raat NJ, Kanias T, et al. Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion. Circulation 2011; 124(4): 465-76.
65. Reynolds JD, Ahearn GS, Angelo M, et al. S-nitrosohemoglobin deficiency: a mechanism for loss of physiological activity in banked blood. Proc Natl Acad Sci U S A 2007; 104(43): 17058-62.
66. Yalcin O, Ortiz D, Tsai AG, et al. Microhemodynamic aberrations created by transfusion of stored blood. Transfusion 2013; 54(4): 1051-27.
67. Refaai MA, Blumberg N. Transfusion immunomodulation from a clinical perspective: an update. Expert Rev Hematol 2013; 6(6): 653-63.
68. Shehata N, Wilson K, Mazer CD, et al. The proportion of variation in perioperative transfusion decisions in Canada attributable to the hospital: [La proportion de variation dans les pratiques transfusionnelles perioperatoires au Canada imputable aux hopitaux]. Can J Anaesth 2007; 54(11): 902-7.
69. Daly DJ, Myles PS, Smith JA, et al. Anticoagulation, bleeding and blood transfusion practices in Australasian cardiac surgical practice. Anaesth Intens Care 2007; 35(5): 760-8.
70. Grey DE, Smith V, Villanueva G, et al. The utility of an automated electronic system to monitor and audit transfusion practice. Vox Sang 2006; 90(4): 316-24.
71. Gombotz H, Rehak PH, Shander A, Hofmann A. Blood use in elective surgery: the Austrian benchmark study. Transfusion 2007; 47(8): 1468-80.
72. Rao SV, Chiswell K, Sun JL, et al. International variation in the use of blood transfusion in patients with non-ST-segment elevation acute coronary syndromes. Am J Cardiol 2008; 101(1): 25-9.
73. Gombotz H, Rehak PH, Shander A, Hofmann A. The second Austrian benchmark study for blood use in elective surgery: results and practice change. Transfusion 2014; 54(10 Pt 2): 2646-57.
74. Spahn DR. Anemia and patient blood management in hip and knee surgery: a systematic review of the literature. Anesthesiology 2010; 113(2): 482-95.
75. Bennett-Guerrero E, Zhao Y, O'Brien SM, et al. Variation in use of blood transfusion in coronary artery bypass graft surgery. JAMA 2010; 304(14): 1568-75.
76. Acheson AG, Brookes MJ, Spahn DR. Effects of allogeneic red blood cell transfusions on clinical outcomes in patients undergoing colorectal cancer surgery: a systematic review and meta-analysis. Ann Surg 2012; 256(2): 235-44.
77. Hutton B, Fergusson D, Tinmouth A, et al. Transfusion rates vary significantly amongst Canadian medical centres. Can J Anaesth 2005; 52(6): 581-90.
78. Yang X, Alexander KP, Chen AY, et al. The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. J Am Coll Cardiol 2005; 46(8): 1490-5.
79. Frank SM, Savage WJ, Rothschild JA, et al. Variability in blood and blood component utilization as assessed by an anesthesia information management system. Anesthesiology 2012; 117(1): 99-106.
80. Seeber P, Shander A. Basics of blood management. Massachusetts: Blackwell Publishing 2008.
81. Frenzel T, Van Aken H, Westphal M. Our own blood is still the best thing to have in our veins. Curr Opin Anaesthesiol 2008; 21(5): 657-63.
82. Rosencrantz D, Shander A, Ozawa S, Spence R, eds. Transfusion medicine and alternatives to blood transfusion. Paris: R& J Editions Medicales 2000.
83. Van der Linden P, Dierick A. Blood conservation strategies in cardiac surgery. Vox Sang 2007; 92(2): 103-12.
84. Spahn DR, Casutt M. Eliminating blood transfusions: new aspects and perspectives. Anesthesiology 2000; 93(1): 242-55.
85. Spiess BD, Spence R, Shander A, eds. Perioperative transfusion medicine. Philadelphia: Lippincott Williams & Wilkins 2006.
86. Kotter JP, Schlesinger LA. Choosing strategies for change. Harv Bus Rev 1979; 57(2): 106-14.
87. Mukhtar S, Leahy M, Koay K, et al. Effectiveness of a patient blood management data system in monitoring blood use in Western Australia. Anaesth Intens Care 2013; 41(2): 207-15.
88. Leahy MF, Roberts H, Mukhtar SA, et al. A pragmatic approach to embedding patient blood management in a tertiary hospital. Transfusion 2014; 54(4): 1133-45.
89. Jackson TJ, Michel JL, Roberts RF, et al. A classification of hospital-acquired diagnoses for use with routine hospital data. Med J Aust 2009; 191(10): 544-8.
90. SMHS. Patient Blood Management: Reducing anaemia, transfusions and length of stay for knee patients The Health Round Table 2012. Available from: https://http://www.healthroundtable.org/GetNews/tabid/668/itemid/172/amid/1858/patientblood- management-program-reducing-anaemia-transfusionslength- of-stay-f.aspx
91. Isbister JP. Clinicians as gatekeepers: what is the best route to optimal blood use? Dev Biol (Basel) 2007; 127: 9-14.
92. Jackson WL, Jr., Shorr AF. Blood transfusion and nosocomial infection: another brick in the wall. Crit Care Med 2006; 34(9): 2488-9.